Skip to content
Search

Latest Stories

Pharmacy First: Only 23% of patients would go to a pharmacist for minor conditions

Pharmacy First: Only 23% of patients would go to a pharmacist for minor conditions

Almost half of patients are unaware of the new service, according to a new survey.

The Pharmacy First Service (PFS) was launched today in England as part of the NHS and government’s primary care access recovery plan, which is aimed at making accessing healthcare easier and more convenient for millions of people.


It is also expected to help reduce NHS waiting lists by freeing up 10 million GP appointments a year.

However, a new survey by NHS-integrated pharmacy tech platform Charac, in partnership with YouGov, revealed that a significant number of people have no awareness of this new service being offered by the community pharmacies.

The survey found that only 23 per cent of patients were using pharmacies as their initial port of call for minor conditions and nearly half of pharmacy patients were unaware of the Pharmacy First Service.

When informed about the new service, the number of patients that would go to pharmacists over GPs rose to 56 per cent for certain conditions, the survey revealed emphasising the need for more awareness around the services offered by pharmacies.

A previous survey by Charac last year found that only 13 per cent of patients were aware of the full scale of services pharmacies provide, with 53 per cent not using pharmacies for anything further than very minor ailments.

Severa pharmacy bodies have raised concerns about the introduction of Pharmacy First amidst the many challenges the sector is facing currently, including funding shortfall and staff shortages.

Santosh Sahu, Founder and CEO of Charac, acknowledged that many community pharmacies are struggling to cope with an increase in demand, and emphasised that digitisation of the sector is crucial for the successful delivery of the new service.

“Key to pharmacies being able to deliver on the new policy, we believe, is the digitisation of the sector, giving pharmacies an online platform where they can more efficiently manage their administrative processes and also offer new services, such as video consultations.

“Both funding and improved digital access can make a tangible difference in equipping pharmacies for the future,” he said.

Simon Tebbutt, Director of Membership at the National Pharmacy Association (NPA), believes that most people would be willing to go to a pharmacy to get help with a common condition when they become aware of what a pharmacist can offer, as shown by this survey.

“The Pharmacy First initiative will be a Godsend to millions of people who will be able to go straight to a pharmacist for help with everyday health issues.

“We expect more and more people will use this straightforward and helpful route into the NHS as they hear about it.

“Pharmacies are local, expert, reliable and experienced, so a natural place for people to go for advice, treatment or help with many health issues,” he said.

Under the newly launched Pharmacy First scheme, pharmacists will be able to assess and treat patients for the following seven conditions:

  1. Sinusitis
  2. Sore throat
  3. Earache
  4. Infected insect bites
  5. Impetigo
  6. Shingles
  7. Uncomplicated urinary tract infections in women (under the age of 65)

 

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less